Mainland Chinese firms leverage Hong Kong as international expansion hub

Mainland Chinese technology and pharmaceutical companies are increasingly utilizing Hong Kong as a strategic base for global market entry. A major state-owned drugmaker is currently evaluating investment in the Northern Metropolis project, signaling a shift toward deeper integration of Hong Kong's professional services into mainland corporate expansion strategies.